Pharmaceuticals and Healthcare Reports Potassium Voltage Gated Channel Subfamily C Member

Haga clic para leer

Pharmaceuticals and Healthcare Reports
Potassium Voltage Gated Channel Subfamily C Member

Publicado el 5 January 2017 en “Salud y Estado Físico, Salud y Estado Físico”, Idioma — English. 4 páginas.

Descripción de la publicación:

The report provides comprehensive information on the Potassium Voltage Gated Channel Subfamily C Member 1 (Voltage Gated Potassium Channel Subunit Kv3.1 or Voltage Gated Potassium Channel Subunit Kv4 or KCNC1), targeted therapeutics, complete with analysis by indications... , stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. Más

Mostrar Etiquetas

Etiquetas: 2016 potassium voltage gated channel subfamily c member 1 market size and growth

Leer Descargar

Suscríbase GRATIS

Otras publicaciones de “Pharmaceuticals and Healthcare Reports”

Gorlin Syndrome (Basal Cell Nevus Syndrome) Market

Gorlin Syndrome (Basal Cell Nevus Syndrome) Market

Coronary Artery Disease (CAD) (Ischemic Heart Dise

Coronary Artery Disease (CAD) (Ischemic Heart Dise

Chemotherapy Induced Neutropenia Market Size, Shar

Chemotherapy Induced Neutropenia Market Size, Shar

Autism Market Size, Share, Growth, Trends, Analysi

Autism Market Size, Share, Growth, Trends, Analysi

Ver todas las publicaciones